People Background Check
Find People:

Glenn D Rosen, Age 67632 Teresi Ln, Los Altos, CA 94024

Get Report
Known as:
Glenn Dr Rosen Glenn David Rosen
Related to:
Alana Rosen 68 Joshua M Rosen 28

Glenn Rosen Phones & Addresses

632 Teresi Ln, Los Altos Hills, CA 94024 (650) 941-9513

Los Altos, CA

Lawrence Township, NJ

Princeton, NJ

Palo Alto, CA

Sunnyvale, CA

Park Ridge, NJ

Saint Louis, MO

632 Teresi Ln, Los Altos, CA 94024 (415) 424-8633

Show more

Work

Company: Parkside Family Medicine Address: 515 W Chelten Ave Suite 2, Philadelphia, PA 19144 Phones: (215) 848-6700 (Phone)

Education

School / High School: Thomas Jefferson University 1999

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Family Practice, 2009

Mentions for Glenn D Rosen

Career records & work history

Medicine Doctors

Glenn Rosen Photo 1

Dr. Glenn D Rosen, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
Parkside Family Medicine
515 W Chelten Ave Suite 2, Philadelphia, PA 19144
(215) 848-6700 (Phone)
Certifications:
Family Practice, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Parkside Family Medicine
515 W Chelten Ave Suite 2, Philadelphia, PA 19144
Methodist Hospital
2301 South Broad Street, Philadelphia, PA 19148
Education:
Medical School
Thomas Jefferson University
Graduated: 1999
Medical School
Abington Mem Hospital
Graduated: 1999

Glenn D. Rosen

Specialties:
Family Medicine
Work:
Parkside Family Medicine
515 W Chelten Ave STE 2, Philadelphia, PA 19144
(215) 848-6700 (phone) (215) 843-0770 (fax)
Education:
Medical School
Thomas Jefferson University, Jefferson Medical College
Graduated: 1999
Procedures:
Allergen Immunotherapy, Arthrocentesis, Destruction of Benign/Premalignant Skin Lesions, Electrocardiogram (EKG or ECG), Hearing Evaluation, Pulmonary Function Tests, Vaccine Administration
Conditions:
Abnormal Vaginal Bleeding, Acute Pharyngitis, Allergic Rhinitis, Anemia, Anxiety Phobic Disorders, Attention Deficit Disorder (ADD), Bacterial Pneumonia, Bipolar Disorder, Bronchial Asthma, Cardiac Arrhythmia, Carpel Tunnel Syndrome, Chronic Renal Disease, Conduction Disorders, Dermatitis, Diabetes Mellitus (DM), Epilepsy, Fractures, Dislocations, Derangement, and Sprains, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Hemorrhage, Gout, Hearing Loss, Hemorrhoids, Herpes Zoster, Hypertension (HTN), Hyperthyroidism, Infectious Liver Disease, Internal Derangement of Knee Cartilage, Intervertebral Disc Degeneration, Ischemic Stroke, Non-Toxic Goiter, Obstructive Sleep Apnea, Osteoarthritis, Peripheral Nerve Disorders, Phlebitis and Thrombophlebitis, Rheumatoid Arthritis, Rotator Cuff Syndrome and Allied Disorders, Schizophrenia, Sciatica, Abdominal Hernia, Acne, Acute Bronchitis, Acute Pancreatitis, Acute Renal Failure, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Alcohol Dependence, Alopecia Areata, Alzheimer's Disease, Anxiety Dissociative and Somatoform Disorders, Aortic Aneurism, Aortic Valvular Disease, Atherosclerosis, Atrial Fibrillation and Atrial Flutter, Autism, Bell's Palsy, Benign Polyps of the Colon, Benign Prostatic Hypertrophy, Benign Thyroid Diseases, Breast Disorders, Burns, Calculus of the Urinary System, Candidiasis, Candidiasis of Vulva and Vagina, Cardiomyopathy, Cataract, Chronic Bronchitis, Chronic Sinusitis, Congenital Anomalies of the Heart, Constipation, Contact Dermatitis, Dehydration, Dementia, Depressive Disorders, Diabetic Peripheral Neuropathy, Disorders of Lipoid Metabolism, Endometriosis, Erectile Dysfunction (ED), Glaucoma, Heart Failure, Herpes Genitalis, Herpes Simplex, HIV Infection, Hypothyroidism, Inguinal Hernia, Insomnia, Internal Derangement of Knee, Intestinal Obstruction, Intracranial Injury, Iron Deficiency Anemia, Irritable Bowel Syndrome (IBS), Lateral Epicondylitis, Malignant Neoplasm of Female Breast, Menopausal and Postmenopausal Disorders, Migraine Headache, Mitral Valvular Disease, Osteoporosis, Otitis Media, Overweight and Obesity, Parkinson's Disease, Paroxysmal Supreventricular Tachycardia (PSVT), Peptic Ulcer Disease, Plantar Fascitis, Plantar Warts, Pneumonia, Post Traumatic Stress Disorder (PTSD), Primary Angle-Closure Glaucoma, Prostatitis, Psoriasis, Pulmonary Tuberculosis (TB), Sarcoidosis, Septicemia, Sickle-Cell Disease, Skin and Subcutaneous Infections, Spinal Stenosis, Substance Abuse and/or Dependency, Systemic Lupus Erythematosus, Tempromandibular Joint Disorders (TMJ), Tension Headache, Thoracid Aortic Aneurysm, Thyroid Cancer, Tinea Pedis, Tinea Unguium, Transient Cerebral Ischemia, Urinary Incontinence, Urinary Tract Infection (UT), Uterine Leiomyoma, Valvular Heart Disease, Varicose Veins, Venous Embolism and Thrombosis, Ventral Hernia, Vitamin D Deficiency
Languages:
English
Description:
Dr. Rosen graduated from the Thomas Jefferson University, Jefferson Medical College in 1999. He works in Philadelphia, PA and specializes in Family Medicine.
Glenn Rosen Photo 2

Glenn David Rosen, Stanford CA

Specialties:
Internal Medicine
Pulmonary Disease
Critical Care Medicine
Surgery
Work:
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford, CA 94305Stanford Hospital and Clinics
300 Pasteur Dr, Palo Alto, CA 94304
Education:
University of Pennsylvania(1983)
Glenn Rosen Photo 3

Glenn David Rosen, Philadelphia PA

Specialties:
Family Medicine
Work:
Weinstock, Robert M. MD PC
515 W Chelten Ave, Philadelphia, PA 19144
Education:
Thomas Jefferson University (1999)

License Records

Glenn David Rosen

Licenses:
License #: MT010537T - Expired
Category: Medicine
Type: Graduate Medical Trainee

Glenn Rosen resumes & CV records

Resumes

Glenn Rosen Photo 38

Senior Vice President, Pre-Clinical Translational Sciences-Small Molecules

Location:
15 Dix Ln, Lawrenceville, NJ 08648
Industry:
Biotechnology
Work:
Coherus Biosciences
Senior Vice President, Pre-Clinical Translational Sciences-Small Molecules Consultant May 2018 - Mar 2019
Consultant, Biopharma Bristol-Myers Squibb May 2018 - Mar 2019
Head, Discovery Fibrosis Biology Bristol-Myers Squibb Jan 2016 - Sep 2016
Therapeutic Area Head, Early Clinical, Fibrosis and Genetically Defined Deseases Bristol-Myers Squibb Sep 2014 - Dec 2015
Medical Director, Early Clinical, Fibrosis Stanford University 1993 - Aug 2014
Associate Professor of Medicine
Education:
University of Pennsylvania 1979 - 1983
Doctor of Medicine, Doctorates, Medicine
Skills:
Clinical Research, Clinical Trials, Medicine, Medical Education, Molecular Biology, Internal Medicine, Translational Research, Pharmaceutical Industry, Life Sciences, Drug Development, Clinical Trial Design, Cancer, Clinical Development, Healthcare, Oncology, Translational Medicine, Translational Science, Biotechnology, Pulmonary Diseases, Research, Team Leadership, Business Development
Glenn Rosen Photo 39

Sales Director

Industry:
Packaging And Containers
Work:
Pgr Pkg
Sales Director
Glenn Rosen Photo 40

Glenn Rosen

Glenn Rosen Photo 41

Glenn Rosen

Publications & IP owners

Us Patents

Uses Of Diterpenoid Triepoxides As An Anti-Proliferative Agent

US Patent:
6537984, Mar 25, 2003
Filed:
Jun 19, 2001
Appl. No.:
09/884898
Inventors:
Glenn D. Rosen - Stanford CA
Edwin S. Lennox - Stanford CA
John H. Musser - San Carlos CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
Pharmagenesis - Palo Alto CA
International Classification:
A61K 3144
US Classification:
514200, 514468
Abstract:
Combinations of diterpenoid triepoxides and anti-proliferative agents are used in a combination therapy to treat hyperproliferative disorders. Anti-proliferative agents of interest include agents active in killing tumor cells, as well as immunosuppressants, and a variety of other agents that reduce cellular proliferation in targeted tissues. Synergistic combinations provide for comparable or improved therapeutic effects, while lowering adverse side effects.

Uses Of Diterpenoid Triepoxides As An Anti-Proliferative Agent

US Patent:
6599499, Jul 29, 2003
Filed:
Aug 22, 2001
Appl. No.:
09/935794
Inventors:
Glenn D. Rosen - Stanford CA
Edwin S. Lennox - Stanford CA
John H. Musser - San Carlos CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
Pharmagenesis, Inc. - Palo Alto CA
International Classification:
A61B 5055
US Classification:
424 934, 424 9341, 436 64
Abstract:
Combinations of diterpenoid triepoxides and anti-proliferative agents are used in a combination therapy to treat hyperproliferative disorders. Anti-proliferative agents of interest include agents active in killing tumor cells, as well as immunosuppressants, and a variety of other agents that reduce cellular proliferation in targeted tissues. Synergistic combinations provide for comparable or improved therapeutic effects, while lowering adverse side effects.

Uses Of Diterpenoid Triepoxides As An Anti-Proliferative Agent

US Patent:
6949510, Sep 27, 2005
Filed:
Jan 10, 2003
Appl. No.:
10/340101
Inventors:
Glenn D. Rosen - Stanford CA, US
Edwin S. Lennox - Stanford CA, US
John H. Musser - San Carlos CA, US
Assignee:
Pharmagenesis - Palo Alto CA
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K038/00
A61K031/44
A61K031/34
US Classification:
514 11, 514291, 514468
Abstract:
Combinations of diterpenoid triepoxides and anti-proliferative agents are used in a combination therapy to treat hyperproliferative disorders. Anti-proliferative agents of interest include agents active in killing tumor cells, as well as immunosuppressants, and a variety of other agents that reduce cellular proliferation in targeted tissues. Synergistic combinations provide for comparable or improved therapeutic effects, while lowering adverse side effects.

Uses Of Diterpenoid Triepoxides As An Antiproliferative Agent

US Patent:
2003020, Nov 6, 2003
Filed:
May 27, 2003
Appl. No.:
10/446241
Inventors:
Glenn Rosen - Stanford CA, US
Edwin Lennox - Stanford CA, US
John Musser - San Carlos CA, US
International Classification:
A61K031/365
A61K049/00
US Classification:
424/009340, 514/468000
Abstract:
Combinations of diterpenoid triepoxides and anti-proliferative agents are used in a combination therapy to treat hyperproliferative disorders. Anti-proliferative agents of interest include agents active in killing tumor cells, as well as immunosuppressants, and a variety of other agents that reduce cellular proliferation in targeted tissues. Synergistic combinations provide for comparable or improved therapeutic effects, while lowering adverse side effects.

Treatment And Prevention Of Diffuse Parenchymal Lung Disease By Selective Active-Site Mtor Inhibitors

US Patent:
2011031, Dec 29, 2011
Filed:
Jun 28, 2011
Appl. No.:
13/171441
Inventors:
Glenn D. Rosen - Los Altos CA, US
Wen-Teh Chang - San Jose CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 31/519
A61P 29/00
A61P 11/00
A61P 17/00
A61K 31/496
A61K 31/5377
US Classification:
5142325, 5142621, 51425303, 5142342
Abstract:
Embodiments are related to new uses for selective active-site mTOR inhibitors in treating or preventing pulmonary fibrosis in diffuse parenchymal lung disease (DPLD) patients, such as a DPLD of environmental cause, a collagen vascular disease (e.g., scleroderma and rheumatoid arthritis), an idiopathic interstitial pneumonia (e.g., idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia), and sarcoidosis.

Treatment And Prevention Of Diffuse Parenchymal Lung Disease By Selective Active-Site Mtor Inhibitors

US Patent:
2014003, Feb 6, 2014
Filed:
Apr 21, 2013
Appl. No.:
13/867123
Inventors:
Glenn D. Rosen - Los Altos CA, US
Wen-Teh Chang - San Jose CA, US
Assignee:
The Board of Trustees of the Leland Standford Junior University - Palo Alto CA
International Classification:
A61K 31/5377
A61K 49/00
A61K 31/519
US Classification:
424 92, 5142621, 5142325
Abstract:
Provided herein are methods for treating or preventing pulmonary fibrosis in subjects suffering from diffuse parenchymal lung diseases using selective active-site mTOR inhibitors.

Combined Therapy Of Diterpenoid Triepoxides And Death Domain Receptor Ligands For Synergistic Killing Of Tumor Cells

US Patent:
6329148, Dec 11, 2001
Filed:
Feb 15, 2000
Appl. No.:
9/505250
Inventors:
Glenn D. Rosen - Stanford CA
Peter Kao - Stanford CA
Assignee:
The Board of Trustees of the Leland Stanford University - Palo Alto CA
International Classification:
C12Q 168
A01N 6500
A61K 4800
US Classification:
435 6
Abstract:
A synergistic combination of ligands that interact with death domain receptors, and diterpenoid triepoxides is used to increase tumor cell killing by induction of apoptosis. Ligands useful in the invention include TRAIL, TNF-. alpha. , analogs thereof, stabilized multimers thereof, mimetics, etc. Of particular interest are combined therapy with the diterpenoid triepoxides triptolide and derivatives and analogs thereof.

Uses Of Diterpenoid Triepoxides As An Anti-Proliferative Agent

US Patent:
6294546, Sep 25, 2001
Filed:
Aug 30, 1999
Appl. No.:
9/385917
Inventors:
Glenn D. Rosen - Stanford CA
Edwin S. Lennox - Stanford CA
John H. Musser - San Carlos CA
Assignee:
The Broad of Trustees of the Leland Stanford Junior University - Palo Alto CA
Pharmagenesis - Palo Alto CA
International Classification:
A61K 3144
A61K 3134
US Classification:
514280
Abstract:
Combinations of diterpenoid triepoxides and anti-proliferative agents are used in a combination therapy to treat hyperproliferative disorders. Anti-proliferative agents of interest include agents active in killing tumor cells, as well as immunosuppressants, and a variety of other agents that reduce cellular proliferation in targeted tissues. Synergistic combinations provide for comparable or improved therapeutic effects, while lowering adverse side effects.

Possible Relatives

Deanna K Rosen  Deborah J Rosen  Debra K Rosen  Dennis B Rosen  Donald J Rosen  Dorothy S Rosen  Edith Rosen  Glenn A Johnson  Glenn L White  Glenn F Joiner 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.